| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/20/2013 | CN101678077B Novel antiphlogistic-analgesic agent |
| 02/20/2013 | CN101541789B Hydantoin derivatives used as mmp inhibitors |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377909 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 02/19/2013 | US8377908 Fixed-dose association of phytate and zinc |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | CA2551525C Pharmaceutical composition for thrombin peptide derivatives |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2442964C Improved anti-inflammatory herbal composition and method of use |
| 02/14/2013 | WO2013023104A1 Chlorobis copper (i) complex compositions and methods of manufacture and use |
| 02/14/2013 | WO2013021935A1 Compound for treating cartilage disorders |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041034 Treatment of pain with topical diclofenac compounds |
| 02/14/2013 | US20130041026 Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
| 02/14/2013 | US20130041020 Methods of Control and Prophylaxis of Inflammation and Mitigation of Inflammatory Conditions in Companion Animals |
| 02/14/2013 | US20130041019 SDF-1 Binding Nucleic Acids |
| 02/14/2013 | US20130041017 Sirna-based therapy of fibrodyplasia ossificans progressiva (fop) |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041002 Denibulin di-hydrochloride |
| 02/14/2013 | US20130040999 New compounds for alleviation, prevention or treatment of osteoporosis, the preparation thereof and pharmaceutical composition comprising the same |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040995 Novel compounds |
| 02/14/2013 | US20130040994 Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040964 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors |
| 02/14/2013 | US20130040963 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040926 Novel compound |
| 02/14/2013 | US20130040915 Pharmaceutical composition |
| 02/14/2013 | US20130040908 Substitution derivatives of n6-benzyladenosine-5' -monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds |
| 02/14/2013 | US20130040907 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels |
| 02/14/2013 | US20130040894 Inhibition or activation of serine/threonine ulk3 kinase activity |
| 02/14/2013 | US20130039990 Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering |
| 02/14/2013 | US20130039971 Compositions and methods for inhibition of vegf |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039925 Alternative pathway specific antibodies for treating arthritis |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039915 Siglec 15 antibodies in treating bone loss-related disease |
| 02/14/2013 | US20130039897 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/14/2013 | US20130039896 Pharmaceutical kits comprising mesenchymal stem cells |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | CA2844672A1 Chlorobis copper (i) complex compositions and methods of manufacture and use |
| 02/13/2013 | EP2557154A2 Method for increasing activity in human stem cell |
| 02/13/2013 | EP2556841A1 Method for inhibiting bone resorption |
| 02/13/2013 | EP2556147A1 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
| 02/13/2013 | EP2556054A1 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| 02/13/2013 | EP2556053A2 (20s)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1alpha,25-hydroxyvitamin d3 |
| 02/13/2013 | EP2555772A1 Oxazole derivatives useful as modulators of faah |
| 02/13/2013 | CN102933704A Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933214A 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 02/13/2013 | CN102933092A Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals |
| 02/13/2013 | CN102925522A Method for preparing pilose antler peptide dry powder by enzymolysis method |
| 02/13/2013 | CN102925324A Healthcare wine with elderberry and blueberry |
| 02/13/2013 | CN102924607A OGP-AcAP5 fusion protein for treating osteoporosis and thrombosis and nucleic acid for coding same |
| 02/13/2013 | CN102924599A Antibody, as well as application and preparation method thereof |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924587A Long-acting salmon calcitonin analog, and preparation method and use thereof |
| 02/13/2013 | CN102924584A Recombinant lubricin molecules and uses thereof |
| 02/13/2013 | CN102924561A Compound promoting activity of estrogen related receptor alpha (ERR alpha), and its use |
| 02/13/2013 | CN102924363A Crystal forms of saxagliptin and processes for preparing same |
| 02/13/2013 | CN102920994A Pharmaceutical composition containing animal bone polypeptide |
| 02/13/2013 | CN102920992A Injection recombinant follistatin preparation and preparation method |
| 02/13/2013 | CN102920985A Traditional Chinese medicine composition for curing lumbar disc herniation (LDH) |
| 02/13/2013 | CN102920984A Medicine for curing rheumatoid arthritis |
| 02/13/2013 | CN102920974A External medicine composition used for military, sports, surgical, and orthopedic traumas |
| 02/13/2013 | CN102920954A Traditional Chinese medicine composition for treating lumbar disc herniation |
| 02/13/2013 | CN102920922A Magically effective bone pain pill |
| 02/13/2013 | CN102920887A Chinese medicinal composition for treating hyperostosis |
| 02/13/2013 | CN102920886A Medical composition for treating rheumatoid arthritis and preparation method |
| 02/13/2013 | CN102920879A Traditional Chinese medicine composition for treating cervical spondylosis |
| 02/13/2013 | CN102920878A Traditional Chinese medicine (TCM) medicated wine used for curing rheumatism and rheumatoid arthritis and preparation method of TCM medicated wine |
| 02/13/2013 | CN102920876A External Chinese medicinal composition for treating knee osteoarthritis |
| 02/13/2013 | CN102920874A Medicinal paste for treating infection |
| 02/13/2013 | CN102920873A Traditional Chinese medicine formula for treating gout |
| 02/13/2013 | CN102920871A Traditional Chinese medicine for treating rheumatoid bone diseases |
| 02/13/2013 | CN102920848A Health-care liquor for dispelling wind, removing dampness, invigorating kidney and strengthening yang |
| 02/13/2013 | CN102920830A Method for effectively extracting polyphenol from Longan seed |
| 02/13/2013 | CN102920802A Foot bath prescription for home health care |
| 02/13/2013 | CN102920799A Externally coated medicine for treating gout and preparation method thereof |
| 02/13/2013 | CN102920782A Medicine for treating cervical spondylosis and lumbar spondylosis |
| 02/13/2013 | CN102920770A Medicament for treating arthritis and preparation method of medicament |
| 02/13/2013 | CN102920769A Application of eucommia ulmoides bolus in preparation of medicines treating osteoporosis |
| 02/13/2013 | CN102920766A Drug composite for treating Chinese-medicine arthralgia syndromes and preparation of patch of drug composite |
| 02/13/2013 | CN102920743A Application of spirulina in preparation of anti-hyperuricemia and anti-uarthritis medicine or health-care food |
| 02/13/2013 | CN102920713A Application of Gypensapogenin B in medicament for treating osteoporosis caused by anti-estrogenic deficiency |
| 02/13/2013 | CN102920711A Combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 02/13/2013 | CN102920692A Application of (E)-2-(1-hydroyxl-4-cyclohexanone) aethyl-caffeic acid phenethyl ester in preparation of medicament for preventing and treating rheumatoid arthritis |
| 02/13/2013 | CN102920676A Celecoxib chewable tablet and preparation method thereof |
| 02/13/2013 | CN102920674A Technology for preparing hydroxychloroquine sulfate tablets |